NCT07653503
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07653503
Title Neoadjuvant Lymph Node Targeted Immunotherapy in Cervical Cancer: a Feasibility Study (NEOLYNC) (NEOLYNC)
Acronym NEOLYNC
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University Medical Center Groningen
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD


No variant requirements are available.